Products Categories
CAS No.: | 29608-49-9 |
---|---|
Name: | Almitrine dimesylate |
Molecular Structure: | |
Formula: | C26H29F2N7.2(CH4O3S) |
Molecular Weight: | 669.76 |
Synonyms: | 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-N,N-diprop-2-enyl-1,3,5-triazine-2,4-diamine; methanesulfonic acid;Almitrine bismethane sulfonate;Almitrinum [INN-Latin];Vectarion;N,N-Diallyl-6-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1,3,5-triazine-2,4-diamine dimethanesulphonate;Almitrine bismesylate;2,4-Bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine;S 2620 bismethanesulfonate;Almitrin;Almitrina [INN-Spanish];1,3,5-Triazine-2,4-diamine,6-[4-[bis(4-fluorophenyl) methyl]-1-piperazinyl]-N,N'-di-2- propenyl-,dimethanesulfonate;6-(4-(Bis(4-fluorphenyl)methyl)-1-piperazinyl)-N,N-di-2-propenyl-1,3,5-triazin-2,4-diamin;N,N'-diallyl-6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1,3,5-triazine-2,4-diamine dimethanesulphonate; |
EINECS: | 249-726-1 |
Melting Point: | 243° (dec) |
Boiling Point: | 606.2 °C at 760 mmHg |
Flash Point: | 320.4 °C |
Appearance: | COA |
PSA: | 194.71000 |
LogP: | 5.57570 |
What can I do for you?
Get Best Price
The Almitrine dimesylate with its cas register number is 29608-49-9. It also can be called as 2,4-Bis(allylamino)-6-[4-[bis(p-fluorophenyl)methyl]-1-piperazinyl]-s-triazine dimethanesulfonate and the IUPAC Name about this chemical is 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine; methanesulfonic acid.
Physical properties about Almitrine dimesylate are: (1)ACD/LogP: 2.84; (2)#H bond acceptors: 7; (3)#H bond donors: 2; (4)#Freely Rotating Bonds: 8; (5)Polar Surface Area: 51.63Å2; (6)Enthalpy of Vaporization: 90.11 kJ/mol; (7)Vapour Pressure: 1.21E-14 mmHg at 25°C
The Almitrine dimesylate is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CS(=O)(=O)O.CS(=O)(=O)O.C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C
(2)InChI: InChI=1S/C26H29F2N7.2CH4O3S/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20;2*1-5(2,3)4/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33);2*1H3,(H,2,3,4)
(3)InChIKey: MRDBGMJEPGXQHJ-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 370mg/kg (370mg/kg) | Journal de Pharmacologie. Vol. 3, Pg. 363, 1972. | |
mouse | LD50 | intravenous | 207mg/kg (207mg/kg) | Journal de Pharmacologie. Vol. 3, Pg. 363, 1972. | |
mouse | LD50 | oral | > 2gm/kg (2000mg/kg) | Experientia. Vol. 28, Pg. 814, 1972. |